Fenchone Ameliorates Constipation-Predominant Irritable Bowel Syndrome via Modulation of SCF/c-Kit Pathway and Gut Microbiota
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In this study we sought to elucidate the therapeutic effects of fenchone on constipation-predominant irritable bowel syndrome (IBS-C) and the underlying mechanisms. An IBS-C model was established in rats by administration of ice water by gavage for 14 days. Fenchone increased the reduced body weight, number of fecal pellets, fecal moisture, and intestinal transit rate, and decreased the enhanced visceral hypersensitivity in the rat model of IBS-C. In addition, fenchone increased the serum content of excitatory neurotransmitters and decreased the serum content of inhibitory neurotransmitters in the IBS-C rat model. Meanwhile, western blot and immunofluorescence experiments indicated that fenchone increased the expressions of SCF and c-Kit. Furthermore, compared with the IBS-C model group, fenchone increased the relative abundance of Lactobacillus, Blautia, Allobaculum, Subdoligranulum, and Ruminococcaceae_UCG-008, and reduced the relative abundance of Bacteroides, Enterococcus, Alistipes, and Escherichia-Shigella on the genus level. Overall, fenchone ameliorates IBS-C via modulation of the SCF/c-Kit pathway and gut microbiota, and could therefore serve as a novel drug candidate against IBS-C.
Abstract
In this study we sought to elucidate the therapeutic effects of fenchone on constipation-predominant irritable bowel syndrome (IBS-C) and the underlying mechanisms. An IBS-C model was established in rats by administration of ice water by gavage for 14 days. Fenchone increased the reduced body weight, number of fecal pellets, fecal moisture, and intestinal transit rate, and decreased the enhanced visceral hypersensitivity in the rat model of IBS-C. In addition, fenchone increased the serum content of excitatory neurotransmitters and decreased the serum content of inhibitory neurotransmitters in the IBS-C rat model. Meanwhile, western blot and immunofluorescence experiments indicated that fenchone increased the expressions of SCF and c-Kit. Furthermore, compared with the IBS-C model group, fenchone increased the relative abundance of Lactobacillus, Blautia, Allobaculum, Subdoligranulum, and Ruminococcaceae_UCG-008, and reduced the relative abundance of Bacteroides, Enterococcus, Alistipes, and Escherichia-Shigella on the genus level. Overall, fenchone ameliorates IBS-C via modulation of the SCF/c-Kit pathway and gut microbiota, and could therefore serve as a novel drug candidate against IBS-C.
참고문헌 (47)
- Sedky AA, "Tadalafil versus linaclotide in gastrointestinal dysfunction and depressive behavior in constipationpredominant irritable bowel syndrome", Life Sci, 256, pp.117960~ (2020)
- Ling X, "Effects of Chang-Kang-Fang formula on the microbiota-gut-brain axis in rats with irritable bowel syndrome", Front. Pharmacol, 13, pp.778032~ (2022)
- Mishima Y, "Enteric microbiota-mediated serotonergic signaling in pathogenesis of irritable bowel syndrome", Int. J. Mol. Sci, 22, pp.10235~ (2021)
- Siddiqui S, "Tenapanor for constipation-predominant irritable bowel syndrome", Drugs Today(Barc), 56, pp.203~210 (2020)
- Sonu I, "Persistent constipation and abdominal adverse events with newer treatments for constipation", BMJ Open Gastroenterol, 3, pp.e000094~ (2016)
- Qiu Z, "A new regioselective synthesis of the cysteine-rich peptide linaclotide", Molecules, 28, pp.10007~ (2023)
- Annahazi A, "Contribution of the enteric nervous system to autoimmune diseases and irritable bowel syndrome", Adv. Exp. Med. Biol, 1383, pp.1~8 (2022)
- Huang Z, "Transcutaneous electrical acustimulation improves irritable bowel syndrome with constipation by accelerating colon transit and reducing rectal sensation using autonomic mechanisms", Am. J. Gastroenterol, 117, pp.1491~1501 (2022)
- Mokhtar NM, "Clinical assessment and cytokines level in constipation-predominant irritable bowel syndrome participants treated with Lactobacillus-containing cultured milk drink", Acta Gastroenterol. Belg, 84, pp.585~591 (2021)
- Cheng CH, "Plasmon-activated water as a therapeutic strategy in Alzheimer's disease by altering gut microbiota", Aging(Albany NY), 15, pp.3715~3737 (2023)
- Ma M, "Urolithin A alleviates colitis in mice by improving gut microbiota dysbiosis, modulating microbial tryptophan metabolism, and triggering AhR activation", J. Agric. Food Chem, 71, pp.7710~7722 (2023)
- Wu L, "Ethanol extract of Mao Jian green tea attenuates gastrointestinal symptoms in a rat model of irritable bowel syndrome with constipation via the 5-hydroxytryptamine signaling pathway", Foods, 12, pp.1101~ (2023)
- Lim YJ, "Effects of synbiotics among constipated adults in Serdang, Selangor, Malaysia-A Randomised, double-blind, placebo-controlled trial", Nutrients, 10, pp.824~ (2018)
- DuPont AW, "Motility abnormalities in irritable bowel syndrome", Digestion, 89, pp.119~123 (2014)
- Foong D, "Understanding the biology of human interstitial cells of Cajal in gastrointestinal motility", Int. J. Mol. Sci, 21, pp.4540~ (2020)
- Feng J, "Role of stem cell factor in the regulation of ICC proliferation and detrusor contraction in rats with an underactive bladder", Mol. Med. Rep, 16, pp.1516~1522 (2017)
- Valdivieso-Ugarte M, "Antimicrobial, antioxidant, and immunomodulatory properties of essential oils : a systematic review", Nutrients, 11, pp.2786~ (2019)
- Bordbar G, "Efficacy and safety of a novel herbal medicine in the treatment of irritable bowel syndrome : a randomized double-blinded clinical trial", Gastroenterol. Res. Pract, 2020, pp.8213082~ (2020)
- Di Vito M, "Potent in vitro activity of Citrus aurantium essential oil and Vitis vinifera hydrolate against gut yeast isolates from irritable bowel syndrome patients-the right mix for potential therapeutic use", Nutrients, 12, pp.1329~ (2020)
- Pittler MH, "Peppermint oil for irritable bowel syndrome : a critical review and metaanalysis", Am. J. Gastroenterol, 93, pp.1131~1135 (1998)
- Kim T, "Therapeutic potential of volatile terpenes and terpenoids from forests for inflammatory diseases", Int. J. Mol. Sci, 21, pp.2187~ (2020)
- Slavchev I, "Antimycobacterial activity generated by the amide coupling of(-)-fenchone derived aminoalcohol with cinnamic acids and analogues", Bioorg. Med. Chem. Lett, 24, pp.5030~5033 (2014)
- Keskin I, "Effects of Foeniculum vulgare essential oil compounds, fenchone and limonene, on experimental wound healing", Biotech. Histochem, 92, pp.274~282 (2017)
- Pessoa MLS, "Antifungal activity and antidiarrheal activity via antimotility mechanisms of(-)-fenchone in experimental models", World J. Gastroenterol, 26, pp.6795~6809 (2020)
- Filippone A, "A combination of xyloglucan, pea protein and Chia seed ameliorates intestinal barrier integrity and mucosa functionality in a rat model of constipation-predominant irritable bowel syndrome", J. Clin. Med, 11, pp.7073~ (2022)
- Hao M, "Improvement of loperamide-hydrochloride-induced intestinal motility disturbance by Platycodon grandiflorum polysaccharides through effects on gut microbes and colonic serotonin", Front. Cell Infect. Microbiol, 13, pp.1105272~ (2023)
- Gershon MD, "The gut, its microbiome, and the brain : connections and communications", J. Clin. Invest, 131, pp.e143768~ (2021)
- Gershon MD, "5-Hydroxytryptamine(serotonin)in the gastrointestinal tract", Curr. Opin. Endocrinol. Diabetes Obes, 20, pp.14~21 (2013)
- Chen L, "Preventive effects of different fermentation times of shuidouchi on diphenoxylate-induced constipation in mice", Foods, 8, pp.86~ (2019)
- Qian Y, "Preventive effect of Lactobacillus fermentum Lee on activated carbon-induced constipation in mice", Exp. Ther. Med, 9, pp.272~278 (2015)
- Li T, "Laxative effect and mechanism of Tiantian Capsule on loperamide-induced constipation in rats", J. Ethnopharmacol, 266, pp.113411~ (2021)
- Zhang J, "Comparative study on alleviating effect of kiwi berry(Actinidia arguta)polysaccharide and polyphenol extracts on constipated mice", Food Res. Int, 162, pp.112037~ (2022)
- Hu M, "Comparative study of the laxative effects of konjac oligosaccharides and konjac glucomannan on loperamide-induced constipation in rats", Food Funct, 12, pp.7709~7717 (2021)
- Wen Y, "The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome : a systematic review and meta-analysis based on seventeen randomized controlled trials", Int. J. Surg, 79, pp.111~119 (2020)
- Shang X, "Effectiveness and safety of probiotics for patients with constipationpredominant irritable bowel syndrome : a systematic review and meta-analysis of 10 randomized controlled trials", Nutrients, 14, pp.2482~ (2022)
- Quigley EMM, "Randomised clinical trial : efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome", Aliment. Pharmacol. Ther, 57, pp.81~93 (2023)
- Polansky O, "Important metabolic pathways and biological processes expressed by chicken cecal microbiota", Appl. Environ. Microbiol, 82, pp.1569~1576 (2015)
- Zhou W, "A purified fraction of polysaccharides from the fruits of Lycium barbarum L. improves glucose homeostasis and intestinal barrier function in high-fat diet-fed mice", Food Funct, 14, pp.5311~5325 (2023)
- van Muijlwijk GH, "Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader", Gut Microbes, 13, pp.1966278~ (2021)
- Wang Y, "Structural characterization of water-soluble polysaccharide from Arctium lappa and its effects on colitis mice", Carbohydr. Polym, 213, pp.89~99 (2019)
- Cui L, "Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota", Int. J. Biol. Macromol, 166, pp.1035~1045 (2021)
- Ji M, "Correlation between intestinal microflora in irritable bowel syndrome and severity", Dis. Markers, 2022, pp.1031844~ (2022)
- Wang L, "Gut microbial dysbiosis in the irritable bowel syndrome : a systematic review and meta-analysis of case-control studies", J. Acad. Nutr. Diet, 120, pp.565~586 (2020)
- Cattaneo A, "Association of brain amyloidosis with proinflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly", Neurobiol. Aging, 49, pp.60~68 (2017)
- Grant CV, "Manipulations of the gut microbiome alter chemotherapy-induced inflammation and behavioral side effects in female mice", Brain Behav. Immun, 95, pp.401~412 (2021)
- Parker BJ, "The genus alistipes : gut bacteria with emerging implications to inflammation, cancer, and mental health", Front. Immunol, 11, pp.906~ (2020)
- Hasan R, "Tumor tissue-specific bacterial biomarker panel for colorectal cancer : bacteroides massiliensis, Alistipes species, Alistipes onderdonkii, Bifidobacterium pseudocatenulatum, Corynebacterium appendicis", Arch. Microbiol, 204, pp.348~ (2022)
